07:57:58 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Beskrivning

LandFinland
ListaFirst North Finland
SektorHälsovård
IndustriMedicinteknik
Modulight är verksamma inom teknikbranschen. Bolaget designar, marknadsför och producerar biomedicinska laserprodukter som används inom onkologi, genetik och oftalmologi. Kunderna består primärt av sjukhus och företagskunder verksamma inom medicinteknik. Utöver huvudverksamheten erbjuds även diverse mervärdestjänster. Störst verksamhet återfinns inom Europa.

Kalender

2022-08-19 Kvartalsrapport 2022-Q2
2022-05-03 Ordinarie utdelning MODU 0.00 EUR
2022-05-02 Årsstämma 2022

Prenumeration

2022-03-11 09:20:00

Modulight Corporation published earlier today a press release about publishing the Financial Statement Release. There was an error in the time of the publishing. The actual time is approximately at 09.00 A.M. EET on 15 March, 2022. Below is the corrected press release.

MODULIGHT CORPORATION, PRESS RELEASE 11 MARCH 2022 AT 10:20 A.M. FINNISH TIME
 
Modulight Corporation will publish its Financial Statement Release 2021 on 15 March, 2022 approximately at 09.00 A.M. EET. 
 
Seppo Orsila, the CEO of Modulight, will present the results in a webcast starting at 10.30 AM EET. The webcast will be held in English, and can be accessed at https://modulight.videosync.fi/2021-q4-results. CFO Anca Guina will also join the Q&A.
 
Questions are requested in written format in the webcast portal. The material will be available on the company's website https://www.modulight.com/reports-presentations/ before the event begins.
 
 
For further information, please contact:
CEO: Seppo Orsila, m. +358 40 830 4671 
IR: Ulla Haapanen m. +358 40 830 4676
Email: ir@modulight.com
 
Certified Adviser: Danske Bank A/S, Finland Branch, m. +358 40 414 5358
 
www.modulight.com
Twitter: @modulight, @orsila
 
 
Modulight in brief
 
Modulight Corporation is a biomedical laser company that designs and manufactures products for oncology, ophthalmology and genetics. The company also provides solutions for selected high value-add applications including quantum computing and digital press. The company’s products include medical devices, subsystems, software, cloud services and specialized semiconductors. Modulight's products are used worldwide by many Fortune 500 companies, international pharmaceutical companies, and well-known cancer centers and universities. Modulight was founded in 2000 and is headquartered in Tampere, Finland.